Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neuro-Oncology
•
Medical Oncology
•
Neurology
Do you utilize tumor treating fields in patients with anaplastic Pleomorphic Xanthoastrocytoma PXA III?
Related Questions
How do you approach anti-seizure medication management when it was started by another team for a seizure-naive patient before/after craniotomy for a tumor?
How do you time CSF analysis for suspected CNS lymphoma in patients who are on steroids?
What experience do you have with paralysis or myasthenia like symptoms developing on Temozolomide?
Are you offering Lutathera for multiple recurrent meningiomas?
How do you approach treatment of sub-total resected ZFTA fusion ependymoma after radiation therapy in a young adult?
What is the expected timeframe for the development of radiation myelitis and therapies that have helped with neurologic symptoms?
How well does a negative non-contrast MRI of the brain exclude metastasis in a patient with squamous cell carcinoma of the lung?
When is the best time to try targeted therapy in adult-type diffuse non-IDH glioma?
What is your approach to management of a subtotally resected pineal parenchymal tumor of intermediate differentiation (CNS WHO grade 2)?
How do you manage follow up for patient who was diagnosed with pineal gland germinomas with drop metastatic to the spinal cord?
